Tone mix
Week by week 52 weeks
Share of BioNTech SE American Depositary Share's 351 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 13, 2026 · tone +99BioNTech's (BNTX) Buy Rating Reiterated at Berenberg Bank+110
- Week of Apr 27, 2026 · tone +100BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data+105
- Week of Jun 22, 2026 · tone -98Alarm at BMW! Sell-off at BioNTech! Desert Gold Undervalued! | 2026-06-24 | Investing News-82
- Week of Apr 6, 2026 · tone -99HC Wainwright Cuts BioNTech (NASDAQ:BNTX) Price Target to $130.00-81
- Week of Mar 23, 2026 · tone +73BioNTech's (BNTX) Buy Rating Reaffirmed at Jefferies Financial Group+78
- Week of Jun 1, 2026 · tone +83Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial+76
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about BioNTech SE American Depositary Share in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 11 | +9 |
| Last 30 sessions | 62 | +14 |
| Last 90 sessions | 148 | +16 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 2 outletsAxsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027?Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Axsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027? | www.fool.com | 2 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletBioNTech (NASDAQ:BNTX) Price Target Cut to $125.00 by Analysts at UBS GroupNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioNTech (NASDAQ:BNTX) Price Target Cut to $125.00 by Analysts at UBS Group | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
4 headlines, average tone +25: 2 positive, 1 neutral and 1 negative. Showing all 4.
- www.rttnews.com · 1 outletBioNTech Reports Q3 Net Profit; Revenue Falls 15% On Lower COVID-19 Vaccine DemandNegative
- aa.com.tr · 1 outletBioNTech returns to profit in 3rd quarter, raises 2026 revenue outlookPositive
- www.rttnews.com · 1 outletBioNTech Q3 Results Show Return To Profitability; Oncology Programs AdvancePositive
- www.fool.com · 1 outletBioNTech (BNTX) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioNTech Reports Q3 Net Profit; Revenue Falls 15% On Lower COVID-19 Vaccine Demand | www.rttnews.com | 1 | Negative |
| BioNTech returns to profit in 3rd quarter, raises 2026 revenue outlook | aa.com.tr | 1 | Positive |
| BioNTech Q3 Results Show Return To Profitability; Oncology Programs Advance | www.rttnews.com | 1 | Positive |
| BioNTech (BNTX) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.manilatimes.net · 1 outletBioNTech Announces Third Quarter 2026 Financial Results and Corporate UpdateNeutral
- www.finanznachrichten.de · 1 outletBioNTech SE: BioNTech Announces Third Quarter 2026 Financial Results and Corporate UpdateNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update | www.manilatimes.net | 1 | Neutral |
| BioNTech SE: BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update | www.finanznachrichten.de | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletHead to Head Contrast: I-Mab (NASDAQ:NBP) & BioNTech (NASDAQ:BNTX)Neutral
- www.hurriyetdailynews.com · 1 outletBioNTech founders receive science awardNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Contrast: I-Mab (NASDAQ:NBP) & BioNTech (NASDAQ:BNTX) | www.dailypolitical.com | 1 | Neutral |
| BioNTech founders receive science award | www.hurriyetdailynews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about BioNTech SE American Depositary Share, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.